AGOURA HILLS, Calif., Aug. 17, 2022 Oncotelic Therapeutics, Inc. , developer of treatments for rare and orphan indications, including Parkinson Disease and various cancers, today announced that. | August 17, 2022
/PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics,.